Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Meghan Trainor and Daryl Sabara's Mounjaro Decision: The Reasons Why - Featured image
Health

Meghan Trainor and Daryl Sabara's Mounjaro Decision: The Reasons Why

Singer Meghan Trainor and actor Daryl Sabara have publicly discussed using Mounjaro. Their decision came after the birth of their children, as they looked for a sustainable way to manage weight and improve their overall health. They combined the medication with diet and exercise.

Shotlee·November 22, 2025·Updated Jan 26, 2026·2 min read
Share:

Meghan Trainor and Daryl Sabara's Mounjaro Decision: The Reasons Why

Singer Meghan Trainor and her husband, actor Daryl Sabara, have publicly shared their experience with the drug Mounjaro. The couple embarked on their health journey following the births of their children, seeking a sustainable method for managing their weight and enhancing their well-being.

Their decision was made after in-depth personal research and consultations with medical experts. According to their "Workin' On It" podcast, they chose Mounjaro after hearing positive feedback from trusted friends and physicians. Health tracking apps like Shotlee can help monitor progress alongside medication.

Previously, Trainor and Sabara had completed the intense 75 Hard fitness program. They put in significant effort to build muscle and establish a solid fitness base. However, after the arrival of their second son, they began exploring alternative options for weight management.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

They specifically chose Mounjaro, a type-2 diabetes medication also utilized for weight loss, over similar drugs. They felt it presented a beneficial profile with potentially fewer adverse effects. This selection was carefully considered alongside their dedication to a healthy way of life.

The couple's strategy was not solely dependent on medication. They initiated treatment with the lowest available dosage of Mounjaro. This was then paired with routine workouts at the gym and a well-rounded, nutritious eating plan.

Their main objective was to reduce weight without losing the muscle mass they had spent years developing. Trainor mentioned that the medication aided in weight loss by diminishing their feelings of hunger. This comprehensive strategy has made them feel self-assured and optimistic regarding their health.

Original source: Bangla news

View original article →
#Meghan Trainor#Daryl Sabara#Mounjaro#weight loss#health#celebrity health
  1. Home
  2. Blog
  3. Meghan Trainor and Daryl Sabara's Mounjaro Decision: The Reasons Why

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community